SDB-006

From WikiMD's WELLNESSPEDIA

SDB-006_structure.png

SDB-006 is a synthetic cannabinoid that belongs to the indazole-3-carboxamide family. It is a designer drug that has been sold online as a "research chemical." SDB-006 is known for its potent agonistic activity at the cannabinoid receptors, specifically the CB1 and CB2 receptors.

Chemical Structure and Properties[edit]

SDB-006 has a chemical structure that includes an indazole core, which is a bicyclic structure composed of a benzene ring fused to a pyrazole ring. The full chemical name of SDB-006 is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide. The molecular formula is C18H26N4O2, and it has a molecular weight of 330.43 g/mol.

Pharmacology[edit]

SDB-006 acts as a potent agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system is involved in regulating various physiological processes, including pain sensation, mood, and appetite. The activation of these receptors by SDB-006 can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.

Legal Status[edit]

The legal status of SDB-006 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. In other regions, it may be legal to possess and distribute for research purposes.

Health Risks and Safety[edit]

The use of SDB-006 has been associated with various adverse effects, including tachycardia, hypertension, nausea, and anxiety. Due to its potency and the lack of clinical studies, the long-term health effects of SDB-006 are not well understood. Users are advised to exercise caution and be aware of the potential risks.

Related Compounds[edit]

SDB-006 is structurally related to other synthetic cannabinoids, such as AB-FUBINACA, ADB-PINACA, and 5F-ADB. These compounds share similar pharmacological profiles and are often found in products marketed as legal alternatives to cannabis.

See Also[edit]

References[edit]


External Links[edit]

Wikimedia Commons logo
Wikimedia Commons has media related to

Synthetic_cannabinoids

.
Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=SDB-006&oldid=5807722"